Article Details
Retrieved on: 2022-10-18 19:15:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
By Denny Jacob 9 Meters Biopharma Inc. shares tumbled 21% to $2.82 following a 1-for-20 reverse stock split. The clinical stage biopharmaceutical ...
Article found on: www.marketwatch.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here